2016
DOI: 10.1073/pnas.1609629113 View full text |Buy / Rent full text
|
|

Abstract: Immunological complexity in atherosclerosis warrants targeted treatment of specific inflammatory cells that aggravate the disease. With the initiation of large phase III trials investigating immunomodulatory drugs for atherosclerosis, cardiovascular disease treatment enters a new era. We here propose a radically different approach: implementing and evaluating in vivo a combinatorial library of nanoparticles with distinct physiochemical properties and differential immune cell specificities. The library's nanopa… Show more

Help me understand this page

Search citation statements

Order By: Relevance
0
0
0
0
0
3
67
0
1

Publication Types

Select...

Relationship

0
0

Authors

Journals